Of the many contributions made by Dr. George Church’s laboratory at Harvard University School of Medicine, a foundational one involves fusing two separate CRISPR guide RNA, namely, crRNA and tracrRNA, as a unified product called “single guide RNA” or sgRNA.11 This fusion product is only 20 base pairs in length, a marker reduction from 30+ base pairs from the two separate guide RNAs. Shortened guide RNA simplifies CRISPR gene-editing complexity, further strengthening CRISPR as a potent gene-editing tool in mammalian cells.
Research at Dr. David Liu’s laboratory at the Broad Institute, a jointly run biomedical research enterprise at Harvard and MIT (Massachusetts Institute of Technology), elevated CRISPR editing capability to the next level by promoting CRISPR research in three areas:12
- DNA-templated synthesis,
- protein evolution and delivery systems, and
- genome editing.
All five CRISPR expert scientists described in this section are also proactively involved in venture capital-supported biomedical start-ups that aim at translating CRISPR gene-editing technology from the laboratory to the clinics.
11. Davies, K., & Church, G. M. (2019). Radical Technology Meets Radical Application: An Interview with George Church. The CRISPR Journal, 2(6), 346–351. https://doi.org/10.1089/crispr.2019.29074.gch12. Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017). Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature, 551(7681), 464–471. https://doi.org/10.1038/nature24644